Scutebarbatine Y exhibits notable neuroprotective properties, making it a subject of interest in research related to neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. It has been shown to modulate key signaling pathways involved in neuronal survival and inflammation, particularly through inhibition of microglial activation, which plays a role in neuroinflammation. Due to its ability to cross the blood-brain barrier, it holds potential as a lead compound for developing therapeutics targeting central nervous system diseases. Additionally, preliminary studies suggest antioxidant effects, further supporting its role in protecting neural tissues from oxidative stress. Current applications remain primarily in preclinical research, focusing on elucidating mechanisms and optimizing bioavailability for future drug development.